We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Novamed, Inc. (MM) | NASDAQ:NOVA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 13.25 | 0 | 00:00:00 |
From Jan 2020 to Jan 2025
Goldfarb Branham LLP is investigating whether the Board of Directors of NovaMed, Inc. (NASDAQ: NOVA) violated shareholder protection laws by agreeing to sell the company to Surgery Center Holdings, Inc. for $13.25 per share. Shareholders – or anyone with knowledge of the transaction – are encouraged to contact Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com.
“This transaction appears undervalued because the buyout price offers no premium over the $13.00 share price that NovaMed stock traded for as recently as January 18, 2011, and also because at least one analyst believes that the stock is worth $18 per share,” said securities lawyer Hamilton Lindley. “Our proposed class action lawsuit seeks to maximize the amount of money and information to shareholders of NovaMed in this transaction."
Goldfarb Branham’s lawyers have significant experience representing individual and institutional investors in over 100 shareholder class action cases. A firm securities lawyer, Hamilton Lindley, can be reached at hlindley@goldfarbbranham.com or 877-583-2855 to discuss the impact of this buyout on NovaMed shareholders.
1 Year Novamed Chart |
1 Month Novamed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
